News Releases Letter to Stockholders Regarding Pending Transaction with GHO Capital Partners LLP and Ampersand Capital Partners Mar 13 2002 Avid Bioservices Announces Manufacturing Supply Agreement for the Production of a Therapeutic Monoclonal Antibody Intended for Phase III Clinical Trials Mar 6 2002 Avid Bioservices Enters Into a Manufacturing and Supply Agreement With Seradyn Mar 4 2002 Peregrine Announces Grant of Patent for New Class of Vascular Targeting Agents Feb 28 2002 Peregrine and OXiGENE Conclude Arcus Therapeutics LLC Joint Venture; Companies Reacquire Full Rights to Respective Vascular Targeting Technologies Feb 4 2002 Peregrine Pharmaceuticals Announces $2.2 Million Investment From Institutional Investors Jan 29 2002 Peregrine Pharmaceuticals Announces Grant of Patent for New Anti-Cancer Antibodies Jan 8 2002 Peregrine Pharmaceuticals Announces Formation of Contract Manufacturing Subsidiary Avid Bioservices Inc. Dec 20 2001 Peregrine Pharmaceuticals Announces the Initiation of Human Antibody Generation Against Two Additional Antigen Targets With Xenerex Biosciences Dec 17 2001 Peregrine Announces Quarterly Conference Call Dec 17 2001 Peregrine Pharmaceuticals Announces Publication of Data Demonstrating Similar Characteristics of Chimeric and Human TNT Monoclonal Antibodies Pagination First page « first Previous page ‹ previous … Page 72 Page 73 Page 74 Page 75 Page 76 Page 77 Page 78 Current page 79 Page 80 Next page next › Last page last »